GridAI Technologies Corp. Common Stock (GRDX)
FairStock Score: 31/100 — RISKY
Key Financials
| Current Price | $5.61 |
| Market Cap | $8M |
| P/E Ratio | -0.99 |
| ROE | —% |
| Dividend Yield | 0% |
| Sector | Healthcare |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I approach this as a Graham-and-Buffett-style analyst: I want proven earnings, a durable moat, and a margin of safety. GridAI does not offer those today. In fiscal Q2 2026, the quarter ended 2026-06-30, it reported revenue of $85,876, net income of -$13.0 million, and diluted EPS of -$2.01. In fiscal Q1 2026, the quarter ended 2026-03-31, revenue was $38,208 and net loss was $3.4 million. In fiscal year 2025, the year ended 2025-12-31, revenue was $36,251, net loss $6.4 million, and EPS -$4.16; in fiscal year 2024, the year ended 2024-12-31, the net loss was $18.1 million. These are not the numbers of a business with pricing power. Trailing free cash flow is -$8.1 million, and FairStock's FCF yield is -105.9%, against a $7.7 million market cap. On the close of 2026-10-13, the $4.55 price gives a FairStock P/E of -0.81, Altman Z-Score of -8.90, Piotroski F-Score of 5/9, and FairStock Score of 31/100. The Lynch category is none because the company has lost money in each of the last four years. The AI platform for utilities and the Adrulipase enzyme program could be optionality, but there is no filed evidence of profitability, scale, or a moat. With negative cash flow and a deeply negative Altman score, the balance sheet looks distressed. I cannot value this on earnings, book, or dividends; the price is a speculative option, not a Graham bargain. I would need to see real revenue, narrowing losses, and positive cash generation before calling it sound.
In plain English: GridAI Technologies is a small healthcare/biotech company that develops AI software and devices to help utilities and big power users manage electricity, plus an enzyme treatment program. The business looks weak: it has very little revenue, large losses, and burns cash. At the $4.55 close on 2026-10-13, the price does not look supported by current profits or cash flow, so versus its numbers it looks expensive and speculative.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K/A (period ended 2023-12-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer